Amgen
AMGN
252,54 €
Share price
-1.70%
Change (1 day)
-15.30%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Amgen (AMGN) - Total debt
Total debt on the balance sheet as of March 2025 : €49.07 Billion
According to Amgen's latest financial reports the company's total debt is €49.07 Billion. A company’s total debt is the sum of all current and non-current debts.
Amgen - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | €57.75 B | -1.19% |
| 2023-12-31 | €58.44 B | 60.99% |
| 2022-12-31 | €36.30 B | 23.44% |
| 2021-12-31 | €29.41 B | 9.67% |
| 2020-12-31 | €26.81 B | 0.47% |
| 2019-12-31 | €26.69 B | -10% |
| 2018-12-31 | €29.65 B | 0.69% |
| 2017-12-31 | €29.45 B | -10.44% |
| 2016-12-31 | €32.89 B | 14.42% |
| 2015-12-31 | €28.74 B | 13.82% |
| 2014-12-31 | €25.25 B | 8.56% |
| 2013-12-31 | €23.26 B | 16% |
| 2012-12-31 | €20.05 B | 21.55% |
| 2011-12-31 | €16.50 B | 64.25% |
| 2010-12-31 | €10.04 B | 35.77% |
| 2009-12-31 | €7.39 B | 1.65% |
| 2008-12-31 | €7.27 B | -4.91% |
| 2007-12-31 | €7.65 B | 12.08% |
| 2006-12-31 | €6.82 B | 104.46% |
| 2005-12-31 | €3.34 B | -11.33% |
| 2004-12-31 | €3.76 B | 53.98% |
| 2003-12-31 | €2.44 B | -19.35% |
| 2002-12-31 | €3.03 B | 729.66% |
| 2001-12-31 | €0.36 B | 6.74% |
| 2000-12-31 | €0.34 B | 6.88% |
| 1999-12-31 | €0.32 B | 15.7% |
| 1998-12-31 | €0.27 B | 26.91% |
| 1997-12-31 | €0.21 B | 46.16% |
| 1996-12-31 | €0.14 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | €52.42 B | 6.81% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | €43.82 B | -10.70% | 🇺🇸 USA |
 GlaxoSmithKline GSK | €20.36 B | -58.50% | 🇬🇧 UK |
 Gilead Sciences GILD | €21.34 B | -56.52% | 🇺🇸 USA |
 Biogen BIIB | €5.66 B | -88.46% | 🇺🇸 USA |
 AbbVie ABBV | €59.77 B | 21.80% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €44.69 B | -8.94% | 🇺🇸 USA |
 Illumina ILMN | €2.22 B | -95.46% | 🇺🇸 USA |
 Eli Lilly LLY | €32.94 B | -32.88% | 🇺🇸 USA |